One of the oral presentations within this theme evaluated the application of Chimeric antigen receptor (CAR) T cells to treat Graves’ disease (GD), which is an autoimmune disorder that results from autoreactive B cells against thyroid-stimulating hormone receptor (TSHR) and results in the overproduction of thyroid hormones. Here, TSHR is linked to autoimmune disease.